Clicky

Depression

Experimental Therapeutics in Treatment-Resistant Major Depressive Diso

Mandeep Kaur,1 Marsal Sanches2 1Department of Behavioral Medicine, Cone Health, Greensboro, NC, USA; 2UT Health Center of Excellence on Mood Disorders, Faillace Department of Psychiatry & Behavioral Sciences, McGovern Medical School, Houston, TX, USA Correspondence: Mandeep KaurGeneral, Child and Adolescent Psychiatrist Department of Behavioral Medicine, Cone Behavioral Health Hospital, 700 Walter Reed Drive, Greensboro, North

Experimental Therapeutics in Treatment-Resistant Major Depressive Diso Read More »

[Full text] Experimental Therapeutics in Treatment-Resistant Major Depressive Diso

Introduction Globally, more than 264 million people of all ages suffer from depression.1 In 2017, an estimated 17.3 million adults in the United States had at least one major depressive episode, representing 7.1% of all adults.2 Major Depressive Disorder (MDD) is defined as a period of at least two weeks when a person experiences a

[Full text] Experimental Therapeutics in Treatment-Resistant Major Depressive Diso Read More »

Pain, Depression Greatly Impact Quality of Life in Patients With MOGAD-Related Pain

Pain and depression have a significant impact on quality of life (QoL) and activities of daily living (ADL) in patients with Myelin oligodendrocyte glycoprotein-antibody (MOG-ab)-associated disease (MOGAD), but pain and depression remain insufficiently controlled in these patients, according to study findings published in the European Journal of Neurology. This exploratory cross-sectional study included 43 patients

Pain, Depression Greatly Impact Quality of Life in Patients With MOGAD-Related Pain Read More »

Anxiety, Depression Remain Elevated Well into Covid-19 Pandemic

Fall survey of U.S. adults showed persistent increase in mental health issues Anxiety, depression, and other mental health issues related to Covid-19 remained common and well above prepandemic levels among adults in the United States last fall, according to newly published survey results from the Covid-19 Outbreak Public Evaluation (COPE) Initiative. Surveys conducted from April

Anxiety, Depression Remain Elevated Well into Covid-19 Pandemic Read More »

Findings Dispute Personalizing Antidepressant Treatment Based on Total Depression Scores

The widely held assumption that individual differences underlie the variability in the association between total depression scores and antidepressant treatment may not be valid, according to a meta-analysis recently published online in JAMA Psychiatry. Researchers analyzed 91 double-blind, randomized placebo-controlled clinical trials studying the use of antidepressants in major depression. The mean age of the 18,965

Findings Dispute Personalizing Antidepressant Treatment Based on Total Depression Scores Read More »